Abstract
It has been shown recently that the opioid receptor ligand Nalmefene not only lowers alcohol consumption in patients addicted to alcohol but significantly reduces transaminase levels. Whether these effects are related to decreased alcohol consumption or additional pharmacological mechanisms and whether they can prevent …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
